Jove
Visualize
Contact Us

Related Experiment Videos

Medullary thyroid cancer

J F Moley1

  • 1Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

The Surgical Clinics of North America
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Medullary thyroid cancer, a tumor of thyroid C cells, can be sporadic or hereditary. Early detection via genetic testing and sensitive plasma calcitonin markers, alongside surgical intervention, offers the best prognosis for cure and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of the GLUT1 and GLUT9 facilitative glucose transporters in embryonic chondroblasts and mature chondrocytes in ovine articular cartilage.

Cell biology international·2005
Same author

Endocrine pancreatic tumors.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2005
Same author

[Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].

Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same author

Surgical treatment of medullary thyroid carcinoma.

Journal of internal medicine·2003
Same author

Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation.

Osteoarthritis and cartilage·2003
Same author

Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma.

Oncogene·2001
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Endocrinology
  • Genetics

Background:

  • Medullary thyroid cancer (MTC) originates from thyroid C cells.
  • It presents in both sporadic and hereditary forms.
  • Genetic testing and plasma calcitonin levels are key in management.

Purpose of the Study:

  • To summarize the clinical presentation and management of medullary thyroid cancer.
  • To highlight the role of genetic testing and biomarkers.
  • To emphasize the importance of surgical treatment.

Main Methods:

  • Review of clinical settings for MTC (sporadic and hereditary).
  • Discussion of available genetic testing protocols.
  • Evaluation of plasma calcitonin as a diagnostic marker.

Related Experiment Videos

  • Assessment of surgical outcomes for cure and disease management.

    • Main Results:

    • Genetic testing is available for at-risk individuals.
    • Plasma calcitonin is a highly sensitive marker for MTC.
    • Surgery is the primary curative treatment.
    • Surgery is also effective for metastatic and recurrent disease.

    Conclusions:

    • Medullary thyroid cancer requires a multi-faceted management approach.
    • Genetic predisposition and early detection are crucial.
    • Surgical resection remains the cornerstone of treatment for MTC.